Induction of antigen-specific T cell responses in human volunteers after intranasal immunization with a whole-cell pertussis vaccine
- PMID: 10738087
- DOI: 10.1016/s0264-410x(00)00024-4
Induction of antigen-specific T cell responses in human volunteers after intranasal immunization with a whole-cell pertussis vaccine
Abstract
We have studied the ability of an intranasally administered whole-cell pertussis vaccine (WCP) without adjuvant to induce antigen-specific T cell responses in humans. Six adult volunteers were given a vaccine dose (corresponding to 250 microg protein) by nasal spray four times at weekly intervals, and peripheral blood mononuclear cells were assayed for antigen-specific proliferative T cell responses. All six vaccinees had a WCP-specific response, which in four of them remained elevated throughout the 2 month study. All participants also responded to the filamentous haemagglutinin (FHA) antigen, and four of them responded to inactivated pertussis toxin (PTd). A significant correlation between T cell proliferation against WCP and WCP-specific IgA antibody levels in nasal secretions was observed. This demonstrates that intranasal administration of a non-proliferating bacterial vaccine without any additional mucosal adjuvant can induce vaccine-specific T cell responses related to mucosal IgA secretion.
Similar articles
-
A nasal whole-cell pertussis vaccine induces specific systemic and cross-reactive mucosal antibody responses in human volunteers.J Med Microbiol. 2000 Feb;49(2):157-163. doi: 10.1099/0022-1317-49-2-157. J Med Microbiol. 2000. PMID: 10670566 Clinical Trial.
-
Mucosal and systemic antibody responses against an acellular pertussis vaccine in mice after intranasal co-administration with recombinant cholera toxin B subunit as an adjuvant.Vaccine. 2003 Mar 7;21(11-12):1165-73. doi: 10.1016/s0264-410x(02)00516-9. Vaccine. 2003. PMID: 12559794
-
Stimulation of mucosal and systemic antibody responses against Bordetella pertussis filamentous haemagglutinin and recombinant pertussis toxin after nasal administration with chitosan in mice.Vaccine. 1998 Dec;16(20):2039-46. doi: 10.1016/s0264-410x(98)00077-2. Vaccine. 1998. PMID: 9796062
-
Proliferative responses to purified and fractionated Bordetella pertussis antigens in mice immunized with whole-cell pertussis vaccine.Vaccine. 1993;11(4):463-72. doi: 10.1016/0264-410x(93)90289-a. Vaccine. 1993. PMID: 8470432
-
[Topics on Bordetella pertussis vaccine].Nihon Saikingaku Zasshi. 1982 Jul;37(4):761-4. doi: 10.3412/jsb.37.761. Nihon Saikingaku Zasshi. 1982. PMID: 6757473 Review. Japanese. No abstract available.
Cited by
-
Pertussis toxin improves immune responses to a combined pneumococcal antigen and leads to enhanced protection against Streptococcus pneumoniae.Clin Vaccine Immunol. 2014 Jul;21(7):972-81. doi: 10.1128/CVI.00134-14. Epub 2014 May 7. Clin Vaccine Immunol. 2014. PMID: 24807055 Free PMC article.
-
Effects of antigen-expressing immunostimulatory liposomes on chemotaxis and maturation of dendritic cells in vitro and in human skin explants.Pharm Res. 2014 Feb;31(2):516-26. doi: 10.1007/s11095-013-1179-0. Epub 2013 Sep 26. Pharm Res. 2014. PMID: 24072262
-
Protection Elicited by Nasal Immunization with Recombinant Pneumococcal Surface Protein A (rPspA) Adjuvanted with Whole-Cell Pertussis Vaccine (wP) against Co-Colonization of Mice with Streptococcus pneumoniae.PLoS One. 2017 Jan 19;12(1):e0170157. doi: 10.1371/journal.pone.0170157. eCollection 2017. PLoS One. 2017. PMID: 28103277 Free PMC article.
-
Protection of mice against Coccidioides immitis intranasal infection by vaccination with recombinant antigen 2/PRA.Infect Immun. 2002 Jun;70(6):3287-9. doi: 10.1128/IAI.70.6.3287-3289.2002. Infect Immun. 2002. PMID: 12011027 Free PMC article.
-
Whole-Cell and Acellular Pertussis Vaccine: Reflections on Efficacy.Med Princ Pract. 2022;31(4):313-321. doi: 10.1159/000525468. Epub 2022 Jun 13. Med Princ Pract. 2022. PMID: 35696990 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous